Publications by authors named "G K MacLeod"

During gastrulation, Wnt-β-catenin signaling dictates lineage bifurcation generating different mesoderm cell types. However, the specific role of Wnt receptors in mesoderm specification remains elusive. Using selective Frizzled (FZD) and LRP5/6 antibody-based agonists, we examined FZD receptors' function during directed mesoderm differentiation of human pluripotent stem cells (hPSCs).

View Article and Find Full Text PDF

Neurons rely on mitochondria for an efficient supply of ATP and other metabolites. However, while neurons are highly elongated, mitochondria are discrete and limited in number. Due to the slow rates of metabolite diffusion over long distances, it follows that neurons would benefit from an ability to control the distribution of mitochondria to sites of high metabolic activity such as synapses.

View Article and Find Full Text PDF

Every neuron contains the same genomic information but its complement of proteins is the product of countless neuron-specific steps including pre-mRNA splicing. Despite advances in RNA sequencing techniques, pre-mRNA splicing biases that favor one isoform over another are largely inscrutable in live neurons . Here, in , we developed bichromatic fluorescent reporters to investigate alternate splicing of - a gene that codes the pore-forming α -subunit of the primary neuronal voltage-gated Ca channel (VGCC).

View Article and Find Full Text PDF
Article Synopsis
  • Researchers studied breast cancer cells during dormancy to identify vulnerabilities for treatment after tumor removal.
  • They found that a specific protein, class-III PI3K, is crucial for the survival and activity of dormant cancer cells, particularly in a cell line known for prolonged dormancy.
  • Targeting this protein may help reduce metastasis in breast cancer patients by disrupting the signaling pathways that allow dormant cells to thrive and spread.
View Article and Find Full Text PDF

Glioblastoma (GBM) is the most common and lethal primary brain tumor in adults and is driven by self-renewing glioblastoma stem cells (GSC) that persist after therapy and seed treatment-refractory recurrent tumors. GBM tumors display a high degree of intra- and intertumoral heterogeneity that is a prominent barrier to targeted treatment strategies. This heterogeneity extends to GSCs that exist on a gradient between two transcriptional states or subtypes termed developmental and injury response.

View Article and Find Full Text PDF